CYP2C19 and major depressive disorder: Furthermore, the A-G haplotype (rs4986893-rs4244285) correlated with an increased risk in developing MDD (OR = 2.306, p = 0.001), suggesting that the CYP2C19 gene may also be associated with susceptibility to developing MDD beyond its role in antidepressant drug metabolism [41].